- Home
- BTA vs COYA Comparison
BTA vs COYA Comparison
Compare BTA & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTA
- COYA
- Stock Information
- Founded
- BTA 2006
- COYA 2020
- Country
- BTA United States
- COYA United States
- Employees
- BTA N/A
- COYA N/A
- Industry
- BTA Trusts Except Educational Religious and Charitable
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- BTA Finance
- COYA Health Care
- Exchange
- BTA Nasdaq
- COYA Nasdaq
- Market Cap
- BTA 127.4M
- COYA 125.1M
- IPO Year
- BTA N/A
- COYA 2022
- Fundamental
- Price
- BTA $9.35
- COYA $6.00
- Analyst Decision
- BTA
- COYA Strong Buy
- Analyst Count
- BTA 0
- COYA 5
- Target Price
- BTA N/A
- COYA $15.80
- AVG Volume (30 Days)
- BTA 21.9K
- COYA 203.6K
- Earning Date
- BTA 01-01-0001
- COYA 11-12-2025
- Dividend Yield
- BTA 5.22%
- COYA N/A
- EPS Growth
- BTA N/A
- COYA N/A
- EPS
- BTA N/A
- COYA N/A
- Revenue
- BTA N/A
- COYA $3,987,706.00
- Revenue This Year
- BTA N/A
- COYA $40.80
- Revenue Next Year
- BTA N/A
- COYA N/A
- P/E Ratio
- BTA N/A
- COYA N/A
- Revenue Growth
- BTA N/A
- COYA N/A
- 52 Week Low
- BTA $8.59
- COYA $4.65
- 52 Week High
- BTA $10.62
- COYA $8.29
- Technical
- Relative Strength Index (RSI)
- BTA 39.78
- COYA 48.41
- Support Level
- BTA $9.37
- COYA $5.68
- Resistance Level
- BTA $9.50
- COYA $6.20
- Average True Range (ATR)
- BTA 0.08
- COYA 0.35
- MACD
- BTA -0.02
- COYA -0.00
- Stochastic Oscillator
- BTA 15.63
- COYA 66.24
About BTA BlackRock Long-Term Municipal Advantage Trust of Beneficial Interest
Blackrock Long-term Municipal AdtgTrust is a diversified closed-end investment trust. Its investment objective is to provide current income exempt from regular U.S. federal income tax. The fund, under normal market conditions, invests a majority of its managed assets in municipal obligations and derivative instruments with exposure to such municipal obligations, in each case that are expected to pay interest or income that is exempt from U.S. federal income tax. Its investment portfolio comprises dollar-weighted, long-term municipal bonds with a maturity of more than ten years at the time of investment. The fund's investments have exposure to various sectors such as Corporate, Health, County/City/Special District/School District, Transportation, Education, Utilities, State, Tobacco, etc.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.